| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.97 | 0.004 | 0.97 | Antiobesity | 0.914 0.004 CID_10199199 | ||
| 0.749 | 0.003 | 0.9 | 5 Hydroxytryptamine uptake inhibitor | 0.9 0.002 CID_10199199 | CID_10199199 | |
| 0.681 | 0.002 | 0.847 | Adrenaline uptake inhibitor | 0.847 0.002 CID_10199199 | CID_10199199 | |
| 0.644 | 0.005 | 0.644 | Potassium channel (Voltage-sensitive) blocker | 0.336 0.04 CID_10199199 | ||
| 0.598 | 0.008 | 0.598 | HERG channel blocker | 0.255 0.064 CID_10199199 | ||
| 0.563 | 0.023 | 0.563 | Cholesterol antagonist | 0.378 0.054 CID_10199199 | ||
| 0.542 | 0.008 | 0.542 | Potassium channel blocker | 0.309 0.043 CID_10199199 | ||
| 0.521 | 0.003 | 0.521 | Dopamine uptake inhibitor | 0.493 0.003 CID_10199199 | ||
| 0.533 | 0.028 | 0.533 | Aldehyde oxidase inhibitor | 0.334 0.058 CID_10199199 | ||
| 0.502 | 0.002 | 0.546 | Dopamine transporter inhibitor | 0.546 0.002 CID_10199199 | CID_10199199 | |
| 0.432 | 0.04 | 0.56 | 5 Hydroxytryptamine release stimulant | 0.56 0.019 CID_10199199 | CID_10199199 | |
| 0.392 | 0.017 | 0.392 | Anesthetic general | 0.353 0.023 CID_10199199 | ||
| 0.353 | 0.03 | 0.353 | Sigma receptor agonist | 0.242 0.05 CID_10199199 | ||
| 0.331 | 0.032 | 0.337 | 5 Hydroxytryptamine uptake stimulant | 0.337 0.029 CID_10199199 | CID_10199199 | |
| 0.345 | 0.054 | 0.345 | Spasmolytic | 0.246 0.093 CID_10199199 | ||
| 0.281 | 0.048 | 0.3 | Gastrin inhibitor | 0.3 0.033 CID_10199199 | CID_10199199 | |
| 0.276 | 0.05 | 0.297 | Psychostimulant | 0.297 0.044 CID_10199199 | CID_10199199 | |
| 0.279 | 0.062 | 0.285 | Tumour necrosis factor alpha release inhibitor | 0.285 0.059 CID_10199199 | CID_10199199 | |
| 0.33 | 0.12 | 0.33 | Analgesic | 0.287 0.152 CID_10199199 | ||
| 0.218 | 0.02 | 0.218 | Alpha 2b adrenoreceptor antagonist | 0.102 0.073 CID_10199199 | ||
| 0.211 | 0.03 | 0.24 | Neurotensin receptor agonist | 0.24 0.023 CID_10199199 | CID_10199199 | |
| 0.204 | 0.031 | 0.204 | Anesthetic local | 0.116 0.07 CID_10199199 | ||
| 0.209 | 0.051 | 0.209 | Lipocortins synthesis antagonist | 0.191 0.062 CID_10199199 | ||
| 0.232 | 0.075 | 0.232 | Neuropeptide Y2 antagonist | 0.214 0.097 CID_10199199 | ||
| 0.158 | 0.009 | 0.158 | Lanosterol 14 alpha demethylase inhibitor | 0.146 0.013 CID_10199199 | ||
| 0.189 | 0.044 | 0.189 | Arachidonic acid antagonist | 0.165 0.071 CID_10199199 | ||
| 0.246 | 0.107 | 0.246 | Ca(v)3.3 blocker | 0.245 0.109 CID_10199199 | ||
| 0.227 | 0.093 | 0.235 | Tyrosine 3 hydroxylase inhibitor | 0.235 0.084 CID_10199199 | CID_10199199 | |
| 0.165 | 0.037 | 0.172 | Cathepsin H inhibitor | 0.172 0.033 CID_10199199 | CID_10199199 | |
| 0.227 | 0.101 | 0.227 | 5 Hydroxytryptamine 1E antagonist | 0.215 0.114 CID_10199199 | ||
| 0.164 | 0.038 | 0.164 | Cholesterol synthesis inhibitor | 0.113 0.072 CID_10199199 | ||
| 0.126 | 0.005 | 0.126 | Prostaglandin EP3 antagonist | 0.109 0.005 CID_10199199 | ||
| 0.132 | 0.015 | 0.133 | Glutamate release inhibitor | 0.133 0.015 CID_10199199 | CID_10199199 | |
| 0.29 | 0.176 | 0.295 | 5 Hydroxytryptamine release inhibitor | 0.295 0.17 CID_10199199 | CID_10199199 | |
| 0.121 | 0.007 | 0.126 | Vanilloid 4 agonist | 0.126 0.005 CID_10199199 | CID_10199199 | |
| 0.239 | 0.131 | 0.248 | Interleukin 2 agonist | 0.248 0.12 CID_10199199 | CID_10199199 | |
| 0.177 | 0.07 | 0.177 | Tumour necrosis factor antagonist | 0.147 0.104 CID_10199199 | ||
| 0.154 | 0.047 | 0.154 | Pregnane X receptor agonist | 0.142 0.069 CID_10199199 | ||
| 0.174 | 0.07 | 0.174 | Antipruritic | 0.169 0.075 CID_10199199 | ||
| 0.18 | 0.087 | 0.18 | Non-steroidal antiinflammatory agent | 0.173 0.093 CID_10199199 | ||
| 0.127 | 0.036 | 0.127 | Sphingomyelinase inhibitor | 0.122 0.039 CID_10199199 | ||
| 0.102 | 0.014 | 0.102 | Prostaglandin E2 antagonist | 0.091 0.017 CID_10199199 | ||
| 0.167 | 0.084 | 0.167 | Succinate dehydrogenase inhibitor | 0.161 0.094 CID_10199199 | ||
| 0.101 | 0.023 | 0.101 | Estrogen-related receptor beta agonist | 0.09 0.04 CID_10199199 | ||
| 0.086 | 0.015 | 0.086 | Glycine transporter inhibitor | 0.048 0.033 CID_10199199 | ||
| 0.132 | 0.064 | 0.132 | CC chemokine 6 receptor antagonist | 0.122 0.107 CID_10199199 | ||
| 0.13 | 0.064 | 0.131 | Nav1.3 sodium channel blocker | 0.131 0.063 CID_10199199 | CID_10199199 | |
| 0.234 | 0.169 | 0.25 | GABA C receptor rho-3 antagonist | 0.25 0.154 CID_10199199 | CID_10199199 | |
| 0.1 | 0.035 | 0.129 | Opioid kappa receptor antagonist | 0.129 0.021 CID_10199199 | CID_10199199 | |
| 0.117 | 0.056 | 0.117 | Falcipain 3 inhibitor | 0.099 0.071 CID_10199199 | ||
| 0.14 | 0.08 | 0.14 | Thiol protease inhibitor | 0.128 0.099 CID_10199199 | ||
| 0.109 | 0.049 | 0.109 | Falcipain inhibitor | 0.098 0.056 CID_10199199 | ||
| 0.107 | 0.048 | 0.107 | Falcipain 2 inhibitor | 0.095 0.055 CID_10199199 | ||
| 0.094 | 0.039 | 0.094 | Glycine receptor antagonist | 0.083 0.053 CID_10199199 | ||
| 0.222 | 0.17 | 0.222 | Calpain 2 inhibitor | |||
| 0.089 | 0.038 | 0.089 | Analgesic, opioid | 0.077 0.052 CID_10199199 | ||
| 0.15 | 0.102 | 0.156 | ATPase inhibitor | 0.156 0.091 CID_10199199 | CID_10199199 | |
| 0.129 | 0.082 | 0.129 | Nav1.6 sodium channel blocker | |||
| 0.125 | 0.078 | 0.125 | Nav1.2 sodium channel blocker | 0.124 0.079 CID_10199199 | ||
| 0.115 | 0.069 | 0.131 | Calcium channel N-type blocker | 0.131 0.051 CID_10199199 | CID_10199199 | |
| 0.065 | 0.02 | 0.066 | Purinergic P2X antagonist | 0.066 0.02 CID_10199199 | CID_10199199 | |
| 0.136 | 0.091 | 0.136 | Ca2+-transporting ATPase inhibitor | |||
| 0.09 | 0.046 | 0.09 | 3C-Like protease (SARS coronavirus) inhibitor | 0.09 0.047 CID_10199199 | ||
| 0.175 | 0.136 | 0.175 | Immunostimulant | |||
| 0.05 | 0.012 | 0.05 | 2,3-Oxidosqualene-lanosterol cyclase inhibitor | |||
| 0.052 | 0.014 | 0.052 | GABA uptake inhibitor | 0.036 0.033 CID_10199199 | ||
| 0.081 | 0.044 | 0.081 | Sphingosine 1-phosphate receptor antagonist | 0.078 0.05 CID_10199199 | ||
| 0.17 | 0.134 | 0.171 | 5 Hydroxytryptamine 3E antagonist | 0.171 0.132 CID_10199199 | CID_10199199 | |
| 0.06 | 0.024 | 0.072 | Immunoglobulin Fc receptor antagonist | 0.072 0.009 CID_10199199 | CID_10199199 | |
| 0.058 | 0.023 | 0.058 | Squalene epoxidase inhibitor | |||
| 0.177 | 0.142 | 0.203 | Interleukin agonist | 0.203 0.118 CID_10199199 | CID_10199199 | |
| 0.039 | 0.005 | 0.039 | Hedgehog signaling activator | 0.034 0.008 CID_10199199 | ||
| 0.158 | 0.126 | 0.179 | Neurotrophic factor enhancer | 0.179 0.099 CID_10199199 | CID_10199199 | |
| 0.098 | 0.066 | 0.098 | Anabolic | 0.092 0.075 CID_10199199 | ||
| 0.064 | 0.033 | 0.064 | Calcium channel T-type blocker | 0.055 0.045 CID_10199199 | ||
| 0.063 | 0.035 | 0.072 | Cathepsin L inhibitor | 0.072 0.028 CID_10199199 | CID_10199199 | |
| 0.05 | 0.022 | 0.051 | Parathyroid hormone antagonist | 0.051 0.019 CID_10199199 | CID_10199199 | |
| 0.069 | 0.042 | 0.069 | MDM2 inhibitor | 0.065 0.056 CID_10199199 | ||
| 0.054 | 0.029 | 0.054 | Neurokinin antagonist | |||
| 0.046 | 0.022 | 0.047 | Alpha 1L adrenoreceptor agonist | 0.047 0.021 CID_10199199 | CID_10199199 | |
| 0.086 | 0.062 | 0.101 | Opioid antagonist | 0.101 0.047 CID_10199199 | CID_10199199 | |
| 0.045 | 0.022 | 0.059 | Cathepsin L1 inhibitor | 0.059 0.016 CID_10199199 | CID_10199199 | |
| 0.12 | 0.097 | 0.125 | Sphingosine 1-phosphate receptor 2 antagonist | 0.125 0.084 CID_10199199 | CID_10199199 | |
| 0.047 | 0.025 | 0.05 | Melanocortin 4 antagonist | 0.05 0.023 CID_10199199 | CID_10199199 | |
| 0.051 | 0.028 | 0.053 | Melanocortin antagonist | 0.053 0.027 CID_10199199 | CID_10199199 | |
| 0.044 | 0.022 | 0.046 | Cathepsin F inhibitor | 0.046 0.018 CID_10199199 | CID_10199199 | |
| 0.042 | 0.02 | 0.042 | Glycine transporter 1 inhibitor | |||
| 0.062 | 0.04 | 0.066 | Neuraminidase inhibitor | 0.066 0.037 CID_10199199 | CID_10199199 | |
| 0.084 | 0.062 | 0.084 | Alpha 2 adrenoreceptor antagonist | |||
| 0.128 | 0.106 | 0.14 | Adenylate cyclase stimulant | 0.14 0.08 CID_10199199 | CID_10199199 | |
| 0.073 | 0.052 | 0.116 | Rho-associated kinase II inhibitor | 0.116 0.026 CID_10199199 | CID_10199199 | |
| 0.089 | 0.068 | 0.089 | ABCA1 expression enhancer | 0.083 0.08 CID_10199199 | ||
| 0.083 | 0.062 | 0.083 | Antineoplastic alkaloid | |||
| 0.072 | 0.052 | 0.072 | Glycine receptor agonist | |||
| 0.042 | 0.024 | 0.051 | NMDA receptor subunit 3A antagonist | 0.051 0.019 CID_10199199 | CID_10199199 | |
| 0.043 | 0.024 | 0.043 | Kainate receptor agonist | 0.041 0.028 CID_10199199 | ||
| 0.062 | 0.043 | 0.062 | Corticotropin releasing factor 2 receptor antagonist | 0.057 0.054 CID_10199199 | ||
| 0.046 | 0.027 | 0.046 | Opioid kappa receptor agonist | |||
| 0.113 | 0.095 | 0.113 | Calcium channel blocker | 0.112 0.097 CID_10199199 | ||
| 0.101 | 0.083 | 0.107 | Calcium channel (voltage-sensitive) blocker | 0.107 0.075 CID_10199199 | CID_10199199 | |
| 0.047 | 0.029 | 0.047 | Neuraminidase (Influenza A) inhibitor | 0.047 0.028 CID_10199199 | ||
| 0.031 | 0.014 | 0.031 | HCV NS5A inhibitor | |||
| 0.087 | 0.071 | 0.087 | Prolactin inhibitor | |||
| 0.056 | 0.04 | 0.056 | Pregnane X receptor antagonist | |||
| 0.126 | 0.11 | 0.126 | Sphingosine 1-phosphate receptor 5 antagonist | |||
| 0.062 | 0.047 | 0.062 | Dopamine D1 antagonist | |||
| 0.037 | 0.023 | 0.037 | p53 inhibitor | |||
| 0.131 | 0.118 | 0.131 | Heat shock protein 70 antagonist | |||
| 0.051 | 0.039 | 0.051 | Opioid agonist | |||
| 0.024 | 0.012 | 0.024 | Protease (Human cytomegalovirus) inhibitor | 0.021 0.017 CID_10199199 | ||
| 0.052 | 0.04 | 0.052 | Nicotinic alpha3beta2 receptor antagonist | 0.051 0.041 CID_10199199 | ||
| 0.081 | 0.07 | 0.081 | Antiadrenergic | |||
| 0.077 | 0.067 | 0.077 | Calcium antagonist | |||
| 0.105 | 0.096 | 0.105 | Cyclooxygenase 3 inhibitor | 0.103 0.099 CID_10199199 | ||
| 0.077 | 0.069 | 0.077 | Ca(v)3.1 blocker | 0.077 0.071 CID_10199199 | ||
| 0.06 | 0.053 | 0.062 | Neuraminidase (influenza) inhibitor | 0.062 0.049 CID_10199199 | CID_10199199 | |
| 0.136 | 0.129 | 0.151 | 3C-like protease (Human coronavirus) inhibitor | 0.151 0.099 CID_10199199 | CID_10199199 | |
| 0.254 | 0.248 | 0.269 | Caspase 9 stimulant | 0.269 0.229 CID_10199199 | CID_10199199 | |
| 0.057 | 0.051 | 0.058 | Purinergic P2 antagonist | 0.058 0.05 CID_10199199 | CID_10199199 | |
| 0.038 | 0.033 | 0.038 | Neurokinin 2 antagonist | |||
| 0.026 | 0.021 | 0.026 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.015 | 0.011 | 0.023 | NMDA receptor phencyclidine site antagonist | 0.023 0.006 CID_10199199 | CID_10199199 | |
| 0.076 | 0.072 | 0.076 | Adrenaline antagonist | |||
| 0.106 | 0.103 | 0.106 | Sphingosine 1-phosphate receptor 4 antagonist | |||
| 0.068 | 0.065 | 0.068 | GABA aminotransferase inhibitor | |||
| 0.032 | 0.029 | 0.033 | Purinergic P2X7 antagonist | 0.033 0.027 CID_10199199 | CID_10199199 | |
| 0.051 | 0.048 | 0.061 | Cathepsin B inhibitor | 0.061 0.035 CID_10199199 | CID_10199199 | |
| 0.024 | 0.022 | 0.024 | Urotensin II agonist | |||
| 0.098 | 0.095 | 0.103 | Microtubule formation inhibitor | 0.103 0.086 CID_10199199 | CID_10199199 | |
| 0.066 | 0.064 | 0.066 | Na+ K+ transporting ATPase inhibitor | |||
| 0.108 | 0.107 | 0.109 | Protein kinase stimulant | 0.109 0.106 CID_10199199 | CID_10199199 | |
| 0.032 | 0.033 | 0.043 | 5-Alpha-reductase inhibitor | 0.043 0.022 CID_10199199 | CID_10199199 | |
| 0.023 | 0.025 | 0.024 | Cathepsin K inhibitor | 0.024 0.023 CID_10199199 | CID_10199199 | |
| 0.019 | 0.022 | 0.023 | CC chemokine 1 receptor antagonist | 0.023 0.017 CID_10199199 | CID_10199199 | |
| 0.03 | 0.036 | 0.033 | Bombesin 1 receptor antagonist | 0.033 0.031 CID_10199199 | CID_10199199 | |
| 0.113 | 0.124 | 0.122 | Insulin secretagoues | 0.122 0.108 CID_10199199 | CID_10199199 | |
| 0.049 | 0.061 | 0.059 | Cannabinoid CB1 receptor antagonist | 0.059 0.046 CID_10199199 | CID_10199199 | |
| 0.051 | 0.065 | 0.065 | Matrix metalloproteinase inhibitor | 0.065 0.049 CID_10199199 | CID_10199199 | |
| 0.051 | 0.065 | 0.069 | Opioid mu receptor antagonist | 0.069 0.046 CID_10199199 | CID_10199199 | |
| 0.041 | 0.056 | 0.047 | Collagenase inhibitor | 0.047 0.038 CID_10199199 | CID_10199199 | |
| 0.106 | 0.124 | 0.156 | Cell wall synthesis inhibitor | 0.156 0.06 CID_10199199 | CID_10199199 | |
| 0.054 | 0.072 | 0.062 | Cannabinoid receptor antagonist | 0.062 0.059 CID_10199199 | CID_10199199 | |
| 0.034 | 0.054 | 0.051 | NMDA 2A receptor antagonist | 0.051 0.036 CID_10199199 | CID_10199199 | |
| 0.049 | 0.07 | 0.059 | NMDA receptor agonist | 0.059 0.049 CID_10199199 | CID_10199199 | |
| 0.065 | 0.089 | 0.081 | NMDA receptor antagonist | 0.081 0.065 CID_10199199 | CID_10199199 | |
| 0.041 | 0.069 | 0.051 | Matrix metalloproteinase (membrane-type) inhibitor | 0.051 0.045 CID_10199199 | CID_10199199 | |
| 0.037 | 0.066 | 0.047 | Potassium channel (ATP-sensitive) activator | 0.047 0.037 CID_10199199 | CID_10199199 | |
| 0.039 | 0.068 | 0.049 | Potassium channel (Inward rectifier) activator | 0.049 0.038 CID_10199199 | CID_10199199 | |
| 0.029 | 0.058 | 0.036 | Potassium channel Kv1.1 blocker | 0.036 0.031 CID_10199199 | CID_10199199 | |
| 0.03 | 0.062 | 0.049 | Matrix metalloproteinase 1 inhibitor | 0.049 0.039 CID_10199199 | CID_10199199 | |
| 0.032 | 0.067 | 0.038 | VCAM-1 antagonist | 0.038 0.033 CID_10199199 | CID_10199199 | |
| 0.032 | 0.067 | 0.038 | VCAM antagonist | 0.038 0.033 CID_10199199 | CID_10199199 | |
| 0.048 | 0.085 | 0.057 | Caspase 9 inhibitor | 0.057 0.055 CID_10199199 | CID_10199199 | |
| 0.049 | 0.087 | 0.071 | Rho-associated kinase inhibitor | 0.071 0.054 CID_10199199 | CID_10199199 | |
| 0.029 | 0.08 | 0.066 | Beta tubulin antagonist | 0.066 0.036 CID_10199199 | CID_10199199 | |
| 0.034 | 0.086 | 0.051 | Baculoviral IAP repeat-containing protein inhibitor | 0.051 0.019 CID_10199199 | CID_10199199 | |
| 0.238 | 0.307 | 0.292 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.292 0.224 CID_10199199 | CID_10199199 | |
| 0.049 | 0.122 | 0.085 | Ca(v)2.2 blocker | 0.085 0.06 CID_10199199 | CID_10199199 | |
| 0.057 | 0.132 | 0.086 | Potassium channel activator | 0.086 0.066 CID_10199199 | CID_10199199 | |
| 0.172 | 0.262 | 0.217 | Calcium channel activator | 0.217 0.189 CID_10199199 | CID_10199199 | |
| 0.101 | 0.202 | 0.17 | Anticonvulsant | 0.17 0.108 CID_10199199 | CID_10199199 | |
| 0.018 | 0.197 | 0.038 | Antibiotic Aminoglycoside-like | 0.038 0.023 CID_10199199 | CID_10199199 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |